nach oben

Clinical Rheumatology

Erschienen in:

02.01.2021 | Letters of Biomedical and Clinical Research

Female psoriatic arthritis: not just a matter of greater disease activity but of greater routine life impact

verfasst von: Isla Morante-Bolado, Rubén Queiro-Silva

Erschienen in: Clinical Rheumatology | Ausgabe 4/2021

Einloggen, um Zugang zu erhalten

Excerpt

Psoriatic arthritis (PsA) is a chronic immune-mediated joint disease that affects approximately one-third of psoriasis patients. It is a relatively common condition in the general population and one of the main inflammatory arthritis treated in rheumatology clinics [1]. A recent study raised the prevalence of PsA to a figure close to 0.6% of the adult Spanish population [2]. …

Ritchlin CT, Colbert RA, Gladman DD (2017) Psoriatic arthritis. N Engl J Med 376:957–970CrossRef

Romero Pérez A, Queiro R, Seoane-Mato D, Graell E, Chamizo E, Chaves Chaparro L, Rojas Herrera S, Pons Dolset J, Polo Ostáriz MA, Ruiz-Alejos Garrido S, Macía-Villa C, Cruz-Valenciano A, González Gómez ML, Sánchez-Piedra C, Díaz-González F, Bustabad-Reyes S, on behalf of the Proyecto EPISER2016 Working Group (2020) Higher prevalence of psoriatic arthritis in the adult population in Spain? A population-based cross-sectional study. PLoS One 15(6):e0234556CrossRef

Orbai A, Holland R, Leung YY, Tillett W, Goel N, Mchugh N et al (2019) PsAID12 provisionally endorsed at OMERACT 2018 as core outcome measure to assess psoriatic arthritis-specific health-related quality of life in clinical trials. J Rheumatol 46:990–995CrossRef

Kiltz U, van der Heijde D, Boonen A, Cieza A, Stucki G, Khan MA, Maksymowych WP, Marzo-Ortega H, Reveille J, Stebbings S, Bostan C, Braun J (2015) Development of a health index in patients with ankylosing spondylitis (ASAS HI): final result of a global initiative based on the ICF guided by ASAS. Ann Rheum Dis 74:830–835CrossRef

Morante I, Aurrecoechea E, Villa I, Santos M, Riancho L, Queiro R (2020) Construct validity of the ASAS-health index in psoriatic arthritis: a cross-sectional analysis. Rheumatology (Oxford):keaa626 Online ahead of print

Eder L, Thavaneswaran A, Chandran V, Gladman DD (2013) Gender difference in disease expression, radiographic damage and disability among patients with psoriatic arthritis. Ann Rheum Dis 72:578–582CrossRef

Hojgaard P, Ballegaard C, Cordtz R, Zobbe K, Clausen M, Glintborg B et al (2018) Gender differences in biologic treatment outcomes-a study of 1750 patients with psoriatic arthritis using Danish Health Care Registers. Rheumatology (Oxford) 57:1651–1660CrossRef

Orbai AM, Perin J, Gorlier C, Coates LC, Kiltz U, Leung YY et al (2019) Determinants of patient-reported psoriatic arthritis impact of disease: an analysis of the association with gender in 458 patients from 14 countries. Arthritis Care Res. https://doi.org/10.1002/acr.24090

Busquets-Pérez N, Rodriguez-Moreno J, Gómez-Vaquero C, Nolla-Solé JM (2012) Relationship between psoriatic arthritis and moderate–severe psoriasis: analysis of a series of 166 psoriatic arthritis patients selected from a hospital population. Clin Rheumatol 31:139–143CrossRef

10.

Desthieux C, Granger B, Balanescu AR, Balint P, Braun J, Canete JD, Heiberg T, Helliwell PS, Kalyoncu U, Kvien TK, Kiltz U, Niedermayer D, Otsa K, Scrivo R, Smolen J, Stamm TA, Veale DJ, de Vlam K, de Wit M, Gossec L (2017) Determinants of patient-physician discordance in global assessment in psoriatic arthritis: a multicenter European study. Arthritis Care Res 69:1606–1611CrossRef

11.

Queiro R (2020) Mismatch between the impact of disease perceived by patients and the state of clinical remission assessed by physicians in psoriatic arthritis. Clin Exp Rheumatol 38:333–336PubMed

Titel: Female psoriatic arthritis: not just a matter of greater disease activity but of greater routine life impact
verfasst von: Isla Morante-Bolado
Rubén Queiro-Silva
Publikationsdatum: 02.01.2021
Verlag: Springer International Publishing
Erschienen in: Clinical Rheumatology / Ausgabe 4/2021
Print ISSN: 0770-3198
Elektronische ISSN: 1434-9949
DOI: https://doi.org/10.1007/s10067-020-05571-w

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Neu im Fachgebiet Innere Medizin

25.04.2024 | Hypotonie | Nachrichten

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Springer Medizin

Female psoriatic arthritis: not just a matter of greater disease activity but of greater routine life impact

Excerpt

Leitlinien kompakt für die Innere Medizin

Neu im Fachgebiet Innere Medizin

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

Adjuvante Immuntherapie verlängert Leben bei RCC

Alectinib verbessert krankheitsfreies Überleben bei ALK-positivem NSCLC

Update Innere Medizin

Springer Medizin

Excerpt

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 4/2021

Enthesitis may be one of the signs of severe disease in familial Mediterranean fever

COVID-19 and systemic sclerosis: analysis of lifestyle changes during the SARS-CoV-2 pandemic in an Italian single-center cohort

Pulse dose steroid experience among hospitalized patients with systemic lupus erythematosus: a single-center feasibility study

Systematic review of recommendations on the use of methotrexate in rheumatoid arthritis

Bidirectional association between GERD and rheumatoid arthritis: two longitudinal follow-up studies using a national sample cohort

Psychometric properties of the 12-item Knee injury and Osteoarthritis Outcome Score (KOOS-12) Spanish version for people with knee osteoarthritis

Leitlinien kompakt für die Innere Medizin

Neu im Fachgebiet Innere Medizin

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

Adjuvante Immuntherapie verlängert Leben bei RCC

Alectinib verbessert krankheitsfreies Überleben bei ALK-positivem NSCLC

Update Innere Medizin